Medpace Holdings, Inc. (MEDP)
USD 331.0
(-5.02%)
USD 331.0
(-5.02%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 433.37 Million | 388.05 Million | 263.32 Million | 258.67 Million | 201.86 Million | 156.58 Million |
| Net Income | 282.81 Million | 245.36 Million | 181.84 Million | 145.38 Million | 100.44 Million | 73.18 Million |
| Depreciation & Amortization | 26.32 Million | 22.34 Million | 21.11 Million | 19.52 Million | 23.18 Million | 38.8 Million |
| Deferred income taxes | -25.11 Million | -23.01 Million | -37.11 Million | 527 Thousand | 10.05 Million | 3.94 Million |
| Stock-based compensation | 20.51 Million | 21.41 Million | 14.46 Million | 13.78 Million | 20.74 Million | 6.49 Million |
| Change in working capital | 106.48 Million | 106.05 Million | 66.7 Million | 66.25 Million | 35.58 Million | 39.6 Million |
| Other non-cash items | 22.35 Million | 15.88 Million | 16.29 Million | 13.19 Million | 11.85 Million | -5.44 Million |
| Investing Cash Flow | -34.62 Million | -38.74 Million | -31.36 Million | -31.21 Million | -19.14 Million | -16.97 Million |
| Investments in PPE | -36.64 Million | -36.87 Million | -28.27 Million | -31.34 Million | -17.91 Million | -16.02 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 2.01 Million | -1.86 Million | -3.09 Million | 126 Thousand | -1.23 Million | -949 Thousand |
| Financing Cash Flow | -182.64 Million | -775.77 Million | -44.45 Million | -82.28 Million | -73.91 Million | -141.58 Million |
| Debt repayment | -155 Million | -274.2 Million | - | - | -80.43 Million | -142.18 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -144.02 Million | -847.84 Million | -62.09 Million | -98.27 Million | - | - |
| Common Stock Issuance | 11.37 Million | 22.07 Million | 17.64 Million | 15.99 Million | 6.52 Million | 2.48 Million |
| Other Financing Activities | 116.37 Million | 346.27 Million | -44.45 Million | -82.28 Million | -73.91 Million | 608 Thousand |
| Accounts receivables | -48.28 Million | -66.92 Million | -24.98 Million | -5.53 Million | -21.25 Million | -27.04 Million |
| Accounts payables | 1.05 Million | 6.43 Million | 1.86 Million | -2.59 Million | 4.73 Million | 1.34 Million |
| Inventory | 66.19 Million | - | 24.98 Million | 5.53 Million | 21.25 Million | 27.78 Million |
| Other working capital | 87.52 Million | 166.54 Million | 64.84 Million | 68.85 Million | 30.85 Million | 37.51 Million |
| Cash at beginning of period | 28.26 Million | 461.3 Million | 277.76 Million | 131.92 Million | 23.28 Million | 26.49 Million |
| Cash at end of period | 245.44 Million | 28.26 Million | 461.3 Million | 277.76 Million | 131.92 Million | 23.28 Million |
| Capital Expenditure | -36.64 Million | -36.87 Million | -28.27 Million | -31.34 Million | -17.91 Million | -16.02 Million |
| Effect of forex changes on cash | 1.08 Million | -6.57 Million | -3.97 Million | 666 Thousand | -167 Thousand | -1.24 Million |
| Net cash flow / Change in cash | 217.18 Million | -433.03 Million | 183.53 Million | 145.84 Million | 108.63 Million | -3.21 Million |
| Free Cash Flow | 396.72 Million | 351.17 Million | 235.05 Million | 227.33 Million | 183.95 Million | 140.56 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 96.42 Million | 88.35 Million | 102.59 Million | 282.81 Million | 78.29 Million | 70.55 Million |
| Depreciation & Amortization | 7.51 Million | 7.23 Million | 6.99 Million | 26.32 Million | 6.97 Million | 6.87 Million |
| Deferred income taxes | -1.51 Million | -54 Thousand | -865 Thousand | -25.11 Million | -13.8 Million | -7.59 Million |
| Stock-based compensation | 11.72 Million | 3.58 Million | 4.31 Million | 20.51 Million | 5.16 Million | 5 Million |
| Change in working capital | 29 Million | 11.18 Million | 38.18 Million | 106.48 Million | 72.81 Million | 32.9 Million |
| Other non-cash items | 5.91 Million | 41.08 Million | 1.46 Million | 22.35 Million | 6.95 Million | 6.64 Million |
| Investing Cash Flow | -10.48 Million | -12.79 Million | 2.53 Million | -34.62 Million | -7.99 Million | -8.66 Million |
| Investments in PPE | -10.53 Million | -12.87 Million | -5.49 Million | -36.64 Million | -9.98 Million | -8.7 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -10.48 Million | 81 Thousand | 8.02 Million | 2.01 Million | 1.98 Million | 41 Thousand |
| Financing Cash Flow | 6.27 Million | 666 Thousand | 7.66 Million | -182.64 Million | 1.52 Million | -49.27 Million |
| Debt repayment | - | - | - | -155 Million | - | -55 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -144.02 Million | - | - |
| Common Stock Issuance | -8.32 Million | 666 Thousand | 7.66 Million | 11.37 Million | 1.52 Million | 5.72 Million |
| Other Financing Activities | 6.27 Million | 666 Thousand | 7.66 Million | 116.37 Million | 1.52 Million | -49.27 Million |
| Accounts receivables | -10.31 Million | -21.83 Million | 19.11 Million | -48.28 Million | -8.96 Million | -17.58 Million |
| Accounts payables | -576 Thousand | 4.89 Million | -7.35 Million | 1.05 Million | 1.97 Million | -3.26 Million |
| Inventory | - | - | - | 66.19 Million | 8.96 Million | 17.58 Million |
| Other working capital | 39.9 Million | 28.11 Million | 62.7 Million | 87.52 Million | 70.84 Million | 36.17 Million |
| Cash at beginning of period | 510.89 Million | 407.01 Million | 245.44 Million | 28.26 Million | 95.2 Million | 39.13 Million |
| Cash at end of period | 656.9 Million | 510.89 Million | 407.01 Million | 245.44 Million | 245.44 Million | 95.2 Million |
| Capital Expenditure | -10.53 Million | -12.87 Million | -5.49 Million | -36.64 Million | -9.98 Million | -8.7 Million |
| Effect of forex changes on cash | 1.14 Million | -389 Thousand | -1.3 Million | 1.08 Million | 321 Thousand | -382 Thousand |
| Net cash flow / Change in cash | 146 Million | 103.88 Million | 161.56 Million | 217.18 Million | 150.24 Million | 56.06 Million |
| Free Cash Flow | 138.53 Million | 103.52 Million | 147.18 Million | 396.72 Million | 146.4 Million | 105.68 Million |
GCTS
QGO
CITAY
601225
BAY
NEX